Efficacy and safety of sublingual immunotherapy in children aged 6-24 months with rhinitis and bronchial asthma sensitized to house dust mites
Serv The efficacy and safety of sublingual immunotherapy (SLIT) was assessed in patients from Previsora Camagüey Clinic, who were diagnosed with allergic rhinitis and asthma. A retrospective case-control study was carried out. Cases and controls were selected in 62 children from 6 to 24 months of ag...
Main Authors: | Olimpio Rodríguez-Santos, María del Carmen Reyes-Almaguer |
---|---|
Format: | Article |
Language: | English |
Published: |
Finlay Ediciones
2015-11-01
|
Series: | VacciMonitor |
Subjects: | |
Online Access: | http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2015000200005&lng=es&nrm=iso&tlng=es |
Similar Items
-
Long-term efficacy of house dust mite sublingual immunotherapy on clinical and pulmonary function in patients with asthma and allergic rhinitis
by: Makoto Hoshino, MD, PhD, et al.
Published: (2024-05-01) -
Practice parameters for sublingual immunotherapy
by: C. Ortolani, et al.
Published: (2016-02-01) -
Sublingual Immunotherapy with House Dust Extract for House Dust-Mite Allergic Rhinitis in Children
by: Syuji Yonekura, et al.
Published: (2010-01-01) -
The Effectiveness of Sublingual Allergen-Specific Immunotherapy in Children with Allergic Rhinitis
by: M.P. Prokhorova
Published: (2015-09-01) -
Efficacy and safety of house dust mite sublingual immunotherapy tablets in allergic rhinitis: A systematic review and meta-analysis
by: Prapasri Kulalert, MD, PhD, et al.
Published: (2022-09-01)